Pharma Aids Limited (DSE:PHARMAID)

Pharma Aids Statistics

Total Valuation

Pharma Aids has a market cap or net worth of BDT 1.62 billion. The enterprise value is 1.60 billion.

Market Cap	1.62B
Enterprise Value	1.60B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	Dec 8, 2025

Share Statistics

Pharma Aids has 3.12 million shares outstanding.

Current Share Class	3.12M
Shares Outstanding	3.12M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 23.99.

PE Ratio	23.99
Forward PE	n/a
PS Ratio	3.57
PB Ratio	3.57
P/TBV Ratio	3.57
P/FCF Ratio	189.14
P/OCF Ratio	24.47
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.49, with an EV/FCF ratio of 186.94.

EV / Earnings	23.71
EV / Sales	3.52
EV / EBITDA	16.49
EV / EBIT	17.79
EV / FCF	186.94

Financial Position

The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.05.

Current Ratio	3.03
Quick Ratio	1.42
Debt / Equity	0.05
Debt / EBITDA	0.21
Debt / FCF	2.43
Interest Coverage	38.45

Financial Efficiency

Return on equity (ROE) is 16.56% and return on invested capital (ROIC) is 13.14%.

Return on Equity (ROE)	16.56%
Return on Assets (ROA)	10.04%
Return on Invested Capital (ROIC)	13.14%
Return on Capital Employed (ROCE)	19.70%
Revenue Per Employee	4.82M
Profits Per Employee	716,998
Employee Count	94
Asset Turnover	0.81
Inventory Turnover	4.42

Taxes

In the past 12 months, Pharma Aids has paid 20.30 million in taxes.

Income Tax	20.30M
Effective Tax Rate	23.15%

Stock Price Statistics

The stock price has decreased by -12.12% in the last 52 weeks. The beta is -0.09, so Pharma Aids's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	-12.12%
50-Day Moving Average	541.98
200-Day Moving Average	550.10
Relative Strength Index (RSI)	44.56
Average Volume (20 Days)	11,839

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharma Aids had revenue of BDT 453.49 million and earned 67.40 million in profits. Earnings per share was 21.60.

Revenue	453.49M
Gross Profit	139.00M
Operating Income	89.83M
Pretax Income	87.70M
Net Income	67.40M
EBITDA	96.90M
EBIT	89.83M
Earnings Per Share (EPS)	21.60

Balance Sheet

The company has 39.55 million in cash and 20.75 million in debt, giving a net cash position of 18.81 million or 6.03 per share.

Cash & Cash Equivalents	39.55M
Total Debt	20.75M
Net Cash	18.81M
Net Cash Per Share	6.03
Equity (Book Value)	453.40M
Book Value Per Share	145.32
Working Capital	310.21M

Cash Flow

In the last 12 months, operating cash flow was 66.08 million and capital expenditures -57.53 million, giving a free cash flow of 8.55 million.

Operating Cash Flow	66.08M
Capital Expenditures	-57.53M
Free Cash Flow	8.55M
FCF Per Share	2.74

Margins

Gross margin is 30.65%, with operating and profit margins of 19.81% and 14.86%.

Gross Margin	30.65%
Operating Margin	19.81%
Pretax Margin	19.34%
Profit Margin	14.86%
EBITDA Margin	21.37%
EBIT Margin	19.81%
FCF Margin	1.89%

Dividends & Yields

This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.58%.

Dividend Per Share	3.00
Dividend Yield	0.58%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	1
Payout Ratio	11.37%
Buyback Yield	n/a
Shareholder Yield	0.58%
Earnings Yield	4.17%
FCF Yield	0.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.

Last Split Date	Dec 4, 2011
Split Type	Forward
Split Ratio	10

Scores

Pharma Aids has an Altman Z-Score of 9.56 and a Piotroski F-Score of 4.

Altman Z-Score	9.56
Piotroski F-Score	4